Outcome of intravitreal injection of bevacizumab on visual acuity and central macular thickness in patients with diabetic macular edema– a one year longitudinal study at kles dr. prabhakar kore hospital and medical research centre, belagavi

Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/296

Full metadata record

DC Field	Value	Language
dc.contributor.author	Dr.Aazambir Singh Brar, BK0118001	-
dc.date.accessioned	2021-03-19T06:53:21Z	-
dc.date.available	2021-03-19T06:53:21Z	-
dc.date.issued	2021	-
dc.identifier.uri	http://localhost:8080/xmlui/handle/123456789/296	-
dc.description.abstract	To study the outcome intravitreal injection of bevacizumab (IVB) on best corrected visual acuity (BCVA) and central macular thickness (CMT) in patients with DME.	en_US
dc.language.iso	en	en_US
dc.publisher	K.L.E. Academy of Higher Education & Research, Belagavi	en_US
dc.title	Outcome of intravitreal injection of bevacizumab on visual acuity and central macular thickness in patients with diabetic macular edema– a one year longitudinal study at kles dr. prabhakar kore hospital and medical research centre, belagavi	en_US
dc.type	Dissertations	en_US
Appears in Collections:	Ophthalmology MS

Files in This Item:

File	Description	Size	Format
BK0118001 Dr.Aazambir Singh Brar.pdf		3.79 MB	Adobe PDF	View/Open